779 results on '"Hellings, Peter W."'
Search Results
2. A EUFOREA comment on a lost comorbidity of asthma
3. Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial
4. EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients
5. Nasal NO and Its Role in the Physiology of the Nose and Diagnosis
6. The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics
7. Chronic Rhinosinusitis Outcome Registry (CHRINOSOR): Establishment of an International Outcome Registry Driven by mHealth Technology
8. Digital tools in allergy and respiratory care
9. SWOT Analysis of Chronic Rhinosinusitis Care Anno 2022
10. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates inCOVID-19
11. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps
12. Rare presence and function of neuroendocrine cells in the nasal mucosa.
13. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates inCOVID-19
14. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
15. The nasal mutualist Dolosigranulum pigrum AMBR11 supports homeostasis via multiple mechanisms
16. Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
17. The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps
18. EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus.
19. Nasal Obstruction: Overview of Pathophysiology and Presentation of a Clinically Relevant Preoperative Plan for Rhino(Septo)plasty.
20. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.
21. Nasal hyperreactivity in allergic rhinitis and chronic rhinosinusitis with polyps: a role for neuronal pathways.
22. Immunopathological features of air pollution and its impact on inflammatory airway diseases (IAD)
23. Prevalence and triggers of self-reported nasal hyperreactivity in adults with asthma
24. Epithelial barriers in allergy and asthma
25. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence
26. A EUFOREA Comment In Reference to Cost‐Effectiveness Analysis of Inferior Turbinate Reduction and Immunotherapy in Allergic Rhinitis
27. EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care
28. Evaluation of skin prick location on the forearm using a novel skin prick automated test device
29. Mobile Technology in Allergic Rhinitis: Evolution in Management or Revolution in Health and Care?
30. Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis
31. ARIA guideline 2019: treatment of allergic rhinitis in the German health system
32. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study
33. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
34. Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE
35. Correction to “ARIA guideline 2019: treatment of allergic rhinitis in the German health system”
36. Impact of Rhinitis on Work Productivity: A Systematic Review
37. A TRiP Through the Roles of Transient Receptor Potential Cation Channels in Type 2 Upper Airway Inflammation
38. Exercise and Sinonasal Disease
39. The importance of allergic disease in public health: an iCAALL statement
40. EUFOREA Comment on a Misleading Allergic Rhinitis Report [Letter]
41. Reasons for rejection of rhinoplasty seeking patients: a multicentre observational study.
42. Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up.
43. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study.
44. Pulmonary Neuroepithelial Bodies as Hypothetical Immunomodulators: Some New Findings and a Review of the Literature
45. The Audacious Goal of Precision Medicine
46. Endotype-Driven Approach in Rhinitis
47. EUFOREA Approach to Precision Medicine in Respiratory Diseases
48. List of Contributors
49. A EUFOREA comment on a lost comorbidity of asthma
50. Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.